Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 251

Similar articles for PubMed (Select 15896095)

1.

Effects of antidepressants on quality of life in women with premenstrual dysphoric disorder.

Freeman EW.

Pharmacoeconomics. 2005;23(5):433-44. Review.

PMID:
15896095
2.

Treatment of premenstrual dysphoric disorder with selective serotonin reuptake inhibitors.

Luisi AF, Pawasauskas JE.

Pharmacotherapy. 2003 Sep;23(9):1131-40. Review.

3.

[Sertraline in the treatment of premenstrual dysphoric disorder].

Culav-Sumić J, Skocilić Z, Jukić V.

Lijec Vjesn. 1999 Jul-Aug;121(7-8):234-8. Croatian.

PMID:
10573958
4.

Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder.

Pearlstein T, Yonkers KA.

Expert Opin Pharmacother. 2002 Jul;3(7):979-91. Review.

PMID:
12083997
5.

Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo.

Pearlstein TB, Halbreich U, Batzar ED, Brown CS, Endicott J, Frank E, Freeman EW, Harrison WM, Haskett RF, Stout AL, Yonkers KA.

J Clin Psychiatry. 2000 Feb;61(2):101-9.

PMID:
10732657
6.

Duloxetine treatment for women with premenstrual dysphoric disorder: a single-blind trial.

Ramos MG, Hara C, Rocha FL.

Int J Neuropsychopharmacol. 2009 Sep;12(8):1081-8. doi: 10.1017/S1461145709000066. Epub 2009 Feb 27.

PMID:
19250561
7.

[Assessment of premenstrual dysphoric disorder symptoms: population of women in Casablanca].

McHichi alami Kh, Tahiri SM, Moussaoui D, Kadri N.

Encephale. 2002 Nov-Dec;28(6 Pt 1):525-30. French.

PMID:
12506265
8.

Treatment of premenstrual dysphoric disorder with luteal phase dosing of sertraline.

Halbreich U, Kahn LS.

Expert Opin Pharmacother. 2003 Nov;4(11):2065-78. Review.

PMID:
14596660
9.
10.

The role of fluoxetine in the treatment of premenstrual dysphoric disorder.

Romano S, Judge R, Dillon J, Shuler C, Sundell K.

Clin Ther. 1999 Apr;21(4):615-33; discussion 613. Review.

PMID:
10363729
11.

The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD).

Halbreich U, Borenstein J, Pearlstein T, Kahn LS.

Psychoneuroendocrinology. 2003 Aug;28 Suppl 3:1-23. Review.

PMID:
12892987
12.

Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management.

Steiner M.

J Psychiatry Neurosci. 2000 Nov;25(5):459-68. Review.

13.
14.

Pretreatment pattern of symptom expression in premenstrual dysphoric disorder.

Pearlstein T, Yonkers KA, Fayyad R, Gillespie JA.

J Affect Disord. 2005 Apr;85(3):275-82.

PMID:
15780697
15.

Intermittent versus continuous sertraline therapy in the treatment of premenstrual dysphoric disorders.

Alpay FB, Turhan NO.

Int J Fertil Womens Med. 2001 Jul-Aug;46(4):228-31.

PMID:
11563834
16.

Fluoxetine improves functional work capacity in women with premenstrual dysphoric disorder.

Steiner M, Brown E, Trzepacz P, Dillon J, Berger C, Carter D, Reid R, Stewart D.

Arch Womens Ment Health. 2003 Feb;6(1):71-7.

PMID:
12715267
17.

Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs.

Steiner M, Pearlstein T, Cohen LS, Endicott J, Kornstein SG, Roberts C, Roberts DL, Yonkers K.

J Womens Health (Larchmt). 2006 Jan-Feb;15(1):57-69. Review.

PMID:
16417420
18.

Premenstrual dysphoric disorder: is there an economic burden of illness?

Chawla A, Swindle R, Long S, Kennedy S, Sternfeld B.

Med Care. 2002 Nov;40(11):1101-12.

PMID:
12409855
19.

Management strategies for premenstrual syndrome/premenstrual dysphoric disorder.

Jarvis CI, Lynch AM, Morin AK.

Ann Pharmacother. 2008 Jul;42(7):967-78. doi: 10.1345/aph.1K673. Epub 2008 Jun 17.

PMID:
18559957
20.

The pharmacologic management of premenstrual dysphoric disorder.

Rapkin AJ, Winer SA.

Expert Opin Pharmacother. 2008 Feb;9(3):429-45. doi: 10.1517/14656566.9.3.429 . Review.

PMID:
18220493
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk